Overview
Guangzhou Concord Cancer Center (GCCC) is a leading tertiary oncology hospital located in the Sino-Singapore Guangzhou Knowledge City, Huangpu District, Guangzhou. Opened in 2021, the hospital is dedicated exclusively to cancer prevention, diagnosis, treatment, research, education, and international patient care. As China’s largest private oncology hospital, GCCC combines advanced medical technology with a multidisciplinary treatment model to provide comprehensive, personalized cancer care.
One of the hospital’s defining strengths is its Proton Therapy Center, featuring the only proton therapy system in South China. Using the advanced Varian ProBeam system, GCCC delivers highly precise radiation therapy that targets tumors while minimizing radiation exposure to surrounding healthy tissues. In addition to proton therapy, the hospital offers photon radiotherapy, medical oncology, surgical oncology, chemotherapy, targeted therapy, immunotherapy, precision diagnostics, and supportive cancer care.
GCCC follows an integrated Multidisciplinary Team (MDT) approach, bringing together specialists from multiple disciplines to develop individualized treatment plans for each patient. The hospital emphasizes evidence-based medicine, international clinical standards, and patient-centered care, enabling patients to receive coordinated treatment throughout every stage of their cancer journey.
The center was developed with guidance from internationally recognized institutions, including The University of Texas MD Anderson Cancer Center and Mayo Clinic, supporting physician training, multidisciplinary consultation, clinical quality improvement, and international collaboration. These partnerships help GCCC maintain high standards in oncology practice while expanding access to advanced cancer care for patients from China and overseas.
Beyond clinical services, Guangzhou Concord Cancer Center serves as a comprehensive oncology platform integrating clinical care, cancer prevention, medical research, specialist training, and telemedicine. The hospital actively participates in academic research, clinical innovation, and international collaboration, contributing to the advancement of precision oncology in China.
For international patients, GCCC provides dedicated support services, including medical consultation, appointment coordination, English-speaking assistance, treatment planning, accommodation arrangements, and follow-up care. Its combination of advanced technology, internationally trained specialists, and comprehensive patient services has made Guangzhou Concord Cancer Center an emerging destination for patients seeking advanced cancer treatment in China.
